Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports

18.04.2024 | Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Focused Update on Migraine and Vertigo Comorbidity

verfasst von: Tzu-Chou Huang, Qadeer Arshad, Amir Kheradmand

Erschienen in: Current Pain and Headache Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To provide an update on comorbidity of vestibular symptoms and migraine.

Recent Findings

Multisensory processing and integration is a key concept for understanding mixed presentation of migraine and vestibular symptoms. Here, we discuss how vestibular migraine should be distinguished from a secondary migraine phenomenon in which migraine symptoms may coincide with or triggered by another vestibular disorder. We also have some updates on the diagnostic criteria of vestibular migraine, its pathophysiology, and common approaches used for its treatment.

Summary

As a common clinical presentation of migraine and vestibular symptoms, vestibular migraine should be distinguished from a secondary migraine phenomenon, in which migraine symptoms may be triggered by or coincide with another vestibular disorder. Recent experimental evidence suggests vestibular symptoms in vestibular migraine are linked to multisensory mechanisms that control body motion and orientation in space.
Literatur
1.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
2.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
3.
•• Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria (update)1. J Vestib Res. 2022;32(1):1–6. Diagnostic criteria for VM.PubMedPubMedCentralCrossRef
4.
Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167.PubMedCrossRef
5.
Ori M, Arra G, Caricato M, Freccia R, Frati F, De Bonis T, et al. Age-related features in vestibular migraine onset: a multiparametric analysis. Cephalalgia. 2020;40(14):1605–13.PubMedCrossRef
6.
Viana M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G, et al. Variability of the characteristics of a migraine attack within patients. Cephalalgia. 2016;36(9):825–30.PubMedCrossRef
7.
Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19(1–2):1–13.PubMedCrossRef
8.
Wattiez AS, O’Shea SA, Ten Eyck P, Sowers LP, Recober A, Russo AF, et al. Patients with vestibular migraine are more likely to have occipital headaches than those with migraine without vestibular symptoms. Headache. 2020;60(8):1581–91.PubMedPubMedCentralCrossRef
9.
Teggi R, Colombo B, Albera R, Asprella Libonati G, Balzanelli C, Batuecas Caletrio A, et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-Phenotypes projects. Headache. 2018;58(4):534–44.PubMedCrossRef
10.
Abouzari M, Goshtasbi K, Moshtaghi O, Tan D, Lin HW, Djalilian HR. Association between vestibular migraine and migraine headache: yet to explore. Otol Neurotol. 2020;41(3):392.PubMedPubMedCentralCrossRef
11.
• Domínguez-Durán E, Doménech-Vadillo E, Bécares-Martínez C, Montilla-Ibáñez MA, Álvarez-Morujo de Sande MG, González-Aguado R, et al. Exploring the frontiers of vestibular migraine: a case series. J Vestib Res Equilib Orientat. 2021;31(2):91–9. A case series of episodic vestibular syndrome without meeting VM criteria.CrossRef
12.
Iljazi A, Ashina H, Lipton RB, Chaudhry B, Al-Khazali HM, Naples JG, et al. Dizziness and vertigo during the prodromal phase and headache phase of migraine: a systematic review and meta-analysis. Cephalalgia. 2020;40(10):1095–103.PubMedPubMedCentralCrossRef
13.
•• Mallampalli MP, Rizk HG, Kheradmand A, Beh SC, Abouzari M, Bassett AM, et al. Care gaps and recommendations in vestibular migraine: an expert panel summit. Front Neurol. 2021;12:812678. An expert panel summit to discuss the challenges in diagnosing and understanding VM.PubMedCrossRef
14.
Radtke A, Neuhauser H, von Brevern M, Hottenrott T, Lempert T. Vestibular migraine - validity of clinical diagnostic criteria. Cephalalgia. 2011;31(8):906–13.PubMedCrossRef
15.
Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J. International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016;36(3):240–8.PubMedCrossRef
16.
Martines F, Dispenza F, Montalbano C, Priola R, Torrente A, La Gumina R, et al. Comparison of electrocochleography and video head impulse test findings in vestibular migraine and Ménière disease: a preliminary study. J Int Adv Otol. 2020;16(2):183–9.PubMedPubMedCentralCrossRef
17.
Salmito MC, Ganança FF. Video head impulse test in vestibular migraine. Braz J Otorhinolaryngol. 2021;87(6):671–7.PubMedCrossRef
18.
Yilmaz MS, Egilmez OK, Kara A, Guven M, Demir D, Genc ES. Comparison of the results of caloric and video head impulse tests in patients with Meniere’s disease and vestibular migraine. Eur Arch Otorhinolaryngol. 2021;278(6):1829–34.PubMedCrossRef
19.
Young AS, Nham B, Bradshaw AP, Calic Z, Pogson JM, D’Souza M, et al. Clinical, oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia. 2021;41(10):1039–52.PubMedCrossRef
20.
Dumas G, Curthoys IS, Lion A, Perrin P, Schmerber S. The skull vibration-induced nystagmus test of vestibular function—a review. Front Neurol. 2017;8:41.PubMedPubMedCentralCrossRef
21.
Koç A, Akkılıç EC. Evaluation of video head impulse test during vertiginous attack in vestibular migraine. Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-facc. 2022;42(3):281–6.
22.
Tabet P, Elblidi A, Saliba I. Vestibular migraine versus Méniere’s disease: diagnostic utility of electrocochleography. Audiol Res. 2022;13(1):12–22.PubMedPubMedCentralCrossRef
23.
Teggi R, Gatti O, Familiari M, Cangiano I, Bussi M. Skull vibration-induced nystagmus test (SVINT) in vestibular migraine and Menière’s disease. Audiol Res. 2021;11(4):603–8.PubMedPubMedCentralCrossRef
24.
Yao Y, Zhao Z, Qi X, Jia H, Zhang L. cVEMP and VAT for the diagnosis of vestibular migraine. Eur J Clin Invest. 2022;52(1):e13657.PubMedCrossRef
25.
Murdin L, Davies RA, Bronstein AM. Vertigo as a migraine trigger. Neurology. 2009;73(8):638–42.PubMedCrossRef
26.
Hegemann SCA. Meniere’s disease caused by CGRP - a new hypothesis explaining etiology and pathophysiology. Redirecting Meniere’s syndrome to Meniere’s disease. J Vestib Res. 2021;31(4):311–4.PubMedCrossRef
27.
Kirsch V, Becker-Bense S, Berman A, Kierig E, Ertl-Wagner B, Dieterich M. Transient endolymphatic hydrops after an attack of vestibular migraine: a longitudinal single case study. J Neurol. 2018;265(1):51–3.PubMedCrossRef
28.
Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Ménière’s disease is there a link? Neurology. 2002;59(11):1700–4.PubMedCrossRef
29.
30.
Chu CH, Liu CJ, Lin LY, Chen TJ, Wang SJ. Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. J Headache Pain. 2015;16:62.PubMedPubMedCentralCrossRef
31.
Hilton DB, Luryi AL, Bojrab DI, Babu SC, Hong RS, Bojrab DI, et al. Comparison of associated comorbid conditions in patients with benign paroxysmal positional vertigo with or without migraine history: a large single institution study. Am J Otolaryngol. 2020;41(6):102650.PubMedCrossRef
32.
Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109(4):377–80.PubMedCrossRef
33.
Kim SK, Hong SM, Park IS, Choi HG. Association between migraine and benign paroxysmal positional vertigo among adults in South Korea. JAMA Otolaryngol Neck Surg. 2019;145(4):307–12.CrossRef
34.
Lempert T, Leopold M, von Brevern M, Neuhauser H. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109(12 Pt 1):1176.PubMed
35.
Teixido M, Baker A, Isildak H. Migraine and benign paroxysmal positional vertigo: a single-institution review. J Laryngol Otol. 2017;131(6):508–13.PubMedCrossRef
36.
El-Badry MM, Samy H, Kabel AM, Rafat FM, Sanyelbhaa H. Clinical criteria of positional vertical nystagmus in vestibular migraine. Acta Otolaryngol (Stockh). 2017;137(7):720–2.PubMedCrossRef
37.
Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurotol. 2010;15(4):241–6.CrossRef
38.
Lee SU, Choi JY, Kim HJ, Kim JS. Recurrent spontaneous vertigo with interictal headshaking nystagmus. Neurology. 2018;90(24):e2135–45.PubMedCrossRef
39.
Huang TC, Wang SJ, Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia. 2020;40(1):107–21.PubMedCrossRef
40.
• Li ZY, Shen B, Si LH, Ling X, Li KZ, Yang X. Clinical characteristics of definite vestibular migraine diagnosed according to criteria jointly formulated by the Bárány Society and the International Headache Society. Braz J Otorhinolaryngol. 2022;88(Suppl 3):S147-54. A cohort study of patients with VM.PubMedPubMedCentralCrossRef
41.
Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2018;39(8):1037–44.CrossRef
42.
Neuhauser HK, Radtke A, Von Brevern M, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33.PubMedCrossRef
43.
Thakar A, Anjaneyulu C, Deka RC. Vertigo syndromes and mechanisms in migraine. J Laryngol Otol. 2001;115(10):782–7.PubMedCrossRef
44.
Zhou C, Zhang L, Jiang X, Shi S, Yu Q, Chen Q, et al. A novel diagnostic prediction model for vestibular migraine. Neuropsychiatr Dis Treat. 2020;16:1845–52.PubMedPubMedCentralCrossRef
45.
Cho SJ, Kim BK, Kim BS, Kim JM, Kim SK, Moon HS, et al. Vestibular migraine in multicenter neurology clinics according to the appendix criteria in the third beta edition of the International Classification of Headache Disorders. Cephalalgia. 2016;36(5):454–62.PubMedCrossRef
46.
Strupp M, Brandt T, Dieterich M. Vestibular Migraine. In: Strupp M, Brandt T, Dieterich M, editors. Vertigo and dizziness: common complaints [Internet]. Cham: Springer International Publishing; 2023 [cited 2024 Jan 28]. p. 285–300. Available from: https://​doi.​org/​10.​1007/​978-3-030-78260-3_​14
47.
Lee H, Jen JC, Cha YH, Nelson SF, Baloh RW. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache. 2008;48(10):1460–7.PubMedCrossRef
48.
Wu X, Qiu F, Wang Z, Liu B, Qi X. Correlation of 5-HTR6 gene polymorphism with vestibular migraine. J Clin Lab Anal. 2020;34(2):e23042.PubMedCrossRef
49.
Balcı B, Akdal G. Imbalance, motion sensitivity, anxiety and handicap in vestibular migraine and migraine only patients. Auris Nasus Larynx. 2020;47(5):747–51.PubMedCrossRef
50.
• Çelebisoy N, Kısabay Ak A, Özdemir HN, Gökçay F, Durmaz GS, Kartı DT, et al. Vestibular migraine, demographic and clinical features of 415 patients: a multicenter study. Clin Neurol Neurosurg. 2022;215:107201. A large cohort study discussing demographic and clinical features of VM.PubMedCrossRef
51.
Murdin L, Chamberlain F, Cheema S, Arshad Q, Gresty MA, Golding JF, et al. Motion sickness in migraine and vestibular disorders. J Neurol Neurosurg Psychiatry. 2015;86(5):585–7.PubMedCrossRef
52.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553–622.PubMedPubMedCentralCrossRef
53.
•• Arshad Q, Moreno-Ajona D, Goadsby PJ, Kheradmand A. What visuospatial perception has taught us about the pathophysiology of vestibular migraine. Curr Opin Neurol. 2024;37(1):32–9. A review of multisensory integration as a key concept in vestibular migraine pathophysiology.PubMedCrossRef
54.
Jones SM, Vijayakumar S, Dow SA, Holt JC, Jordan PM, Luebke AE. Loss of α-calcitonin gene-related peptide (αCGRP) reduces otolith activation timing dynamics and impairs balance. Front Mol Neurosci. 2018;11:289.PubMedPubMedCentralCrossRef
55.
Zhang Y, Zhang Y, Tian K, Wang Y, Fan X, Pan Q, et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain. 2020;21(1):72.PubMedPubMedCentralCrossRef
56.
Karaaslan Z, Özçelik P, Ulukan Ç, Ulusoy C, Orhan KS, Orhan EK, et al. Plasma levels of inflammatory mediators in vestibular migraine. Int J Neurosci. 2020;130(4):330–5.PubMedCrossRef
57.
Tang B, Yu X, Jiang W, Zhang C, Zhan T, He Y. Clinical significance of serum sex hormones in postmenopausal women with vestibular migraine: potential role of estradiol. J Int Med Res. 2021;49(5):3000605211016379.PubMedCrossRef
58.
Wurthmann S, Naegel S, Roesner M, Nsaka M, Scheffler A, Kleinschnitz C, et al. Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: a cross-sectional study. Eur J Neurol. 2021;28(7):2357–66.PubMedCrossRef
59.
Bednarczuk NF, Bonsu A, Ortega MC, Fluri AS, Chan J, Rust H, et al. Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study. Brain. 2019;142(3):606–16.PubMedPubMedCentralCrossRef
60.
King S, Priesol AJ, Davidi SE, Merfeld DM, Ehtemam F, Lewis RF. Self-motion perception is sensitized in vestibular migraine: pathophysiologic and clinical implications. Sci Rep. 2019;9(1):14323.PubMedPubMedCentralCrossRef
61.
62.
Winnick A, Sadeghpour S, Otero-Millan J, Chang TP, Kheradmand A. Errors of upright perception in patients with vestibular migraine. Front Neurol. 2018;9:892.PubMedPubMedCentralCrossRef
63.
• Bonsu AN, Britton Z, Asif Z, Sharif M, Kaski D, Kheradmand A, et al. Migraine phenotype differentially modulates the attentional network: a cross sectional observation study. Cephalalgia Rep. 2022;5:25158163221124264. A study exploring how different migraine phenotypes affect attention networks.
64.
• Sharif M, Saman Y, Burling R, Rea O, Patel R, Barrett DJK, et al. Altered visual conscious awareness in patients with vestibular dysfunctions; a cross-sectional observation study. J Neurol Sci. 2023;448:120617. A study investigating the link between vestibular dysfunction and altered visual awareness.PubMedCrossRef
65.
66.
Lopez C, Blanke O. The thalamocortical vestibular system in animals and humans. Brain Res Rev. 2011;67(1–2):119–46.PubMedCrossRef
67.
Messina R, Rocca MA, Colombo B, Teggi R, Falini A, Comi G, et al. Structural brain abnormalities in patients with vestibular migraine. J Neurol. 2017;264(2):295–303.PubMedCrossRef
68.
Obermann M, Wurthmann S, Steinberg BS, Theysohn N, Diener HC, Naegel S. Central vestibular system modulation in vestibular migraine. Cephalalgia. 2014;34(13):1053–61.PubMedCrossRef
69.
Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, Bernasconi L, et al. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke. 2006;37(7):1765–70.PubMedCrossRef
70.
Wang S, Wang H, Zhao D, Liu X, Yan W, Wang M, et al. Grey matter changes in patients with vestibular migraine. Clin Radiol. 2019;74(11):898.e1-898.e5.PubMedCrossRef
71.
Wurthmann S, Naegel S, Schulte Steinberg B, Theysohn N, Diener HC, Kleinschnitz C, et al. Cerebral gray matter changes in persistent postural perceptual dizziness. J Psychosom Res. 2017;103:95–101.PubMedCrossRef
72.
• Zhe X, Chen L, Zhang D, Tang M, Gao J, Ai K, et al. Cortical areas associated with multisensory integration showing altered morphology and functional connectivity in relation to reduced life quality in vestibular migraine. Front Hum Neurosci. 2021;15:717130. A study suggesting the role for multisensory integration in patients with VM pathophysiology.PubMedPubMedCentralCrossRef
73.
• Li ZY, Si LH, Shen B, Yang X. Altered brain network functional connectivity patterns in patients with vestibular migraine diagnosed according to the diagnostic criteria of the Bárány Society and the International Headache Society. J Neurol. 2022;269(6):3026–36. A study exploring altered functional connectivity patterns in patients with VM.PubMedCrossRef
74.
Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T, Bronstein A. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191–208.PubMedPubMedCentralCrossRef
75.
Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.PubMedCrossRef
76.
Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.PubMedCrossRef
77.
• Chen Z, Xiao L, Liu H, Zhang Q, Wang Q, Lv Y, et al. Altered thalamo-cortical functional connectivity in patients with vestibular migraine: a resting-state fMRI study. Neuroradiology. 2022;64(1):119–27. A study exploring altered functional connectivity patterns in patients with VM.PubMedCrossRef
78.
Roberts RA, Watford KE, Picou EM, Hatton K, Trone TH, Brignola EY. Effects of lifestyle modification on vestibular migraine. Otol Neurotol. 2021;42(10):e1537–43.PubMedCrossRef
79.
Nigmatullina Y, Hellyer PJ, Nachev P, Sharp DJ, Seemungal BM. The neuroanatomical correlates of training-related perceptuo-reflex uncoupling in dancers. Cereb Cortex N Y N 1991. 2015;25(2):554–62.
80.
• Smyth D, Britton Z, Murdin L, Arshad Q, Kaski D. Vestibular migraine treatment: a comprehensive practical review. Brain J Neurol. 2022;145(11):3741–54. A comprehensive practical review for VM treatment.CrossRef
81.
Wang F, Wang J, Cao Y, Xu Z. Serotonin-norepinephrine reuptake inhibitors for the prevention of migraine and vestibular migraine: a systematic review and meta-analysis. Reg Anesth Pain Med. 2020;45(5):323–30.PubMedCrossRef
82.
• Rashid SMU, Sumaria S, Koohi N, Arshad Q, Kaski D. Patient experience of flunarizine for vestibular migraine: single centre observational study. Brain Sci. 2022;12(4):415. An observational study of flunarizine in VM treatment.PubMedPubMedCentralCrossRef
83.
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–36.PubMedCrossRef
84.
• Oh SY, Kang JJ, Kim S, Lee JM, Kim JS, Dieterich M. A preliminary trial of botulinum toxin type A in patients with vestibular migraine: a longitudinal fMRI study. Front Neurol. 2022;13:955158. A longitudinal fMRI study employing BTX-A in VM treatment.PubMedPubMedCentralCrossRef
85.
86.
Russo CV, Saccà F, Braca S, Sansone M, Miele A, Stornaiuolo A, et al. Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: a prospective observational cohort study. Cephalalgia. 2023;43(4):3331024231161809.PubMedCrossRef
87.
Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine. J Neurol Sci. 2020;15(408):116550.CrossRef
88.
Moisset X, Pereira B, Ciampi de Andrade D, Fontaine D, Lantéri-Minet M, Mawet J. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2020;21(1):142.PubMedPubMedCentralCrossRef
89.
Metadaten
Titel
Focused Update on Migraine and Vertigo Comorbidity
verfasst von
Tzu-Chou Huang
Qadeer Arshad
Amir Kheradmand
Publikationsdatum
18.04.2024
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-024-01256-0

Neu im Fachgebiet AINS

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise